CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
暂无分享,去创建一个
Ying Li | Youli Zu | Nan Li | Lidong Qin | M. C. Jo | Zihua Zeng | Kai Zhang | Zihua Zeng | Y. Zu | L. Qin | Zongbin Liu | Kai Zhang | Ying Li | Xin Han | Nan Li | Zongbin Liu | Xin Han | Myeong chan Jo | Lidong Qin
[1] Long-chuan Yu,et al. Microinjection as a tool of mechanical delivery. , 2008, Current opinion in biotechnology.
[2] David T. Curiel,et al. Engineering targeted viral vectors for gene therapy , 2007, Nature Reviews Genetics.
[3] Yu-Chen Hu. Baculoviral vectors for gene delivery: a review. , 2008, Current gene therapy.
[4] Suresh Ramakrishna,et al. Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA , 2014, Genome research.
[5] Zabner,et al. Cationic lipids used in gene transfer. , 1997, Advanced drug delivery reviews.
[6] Kai Zhang,et al. Block-Cell-Printing for live single-cell printing , 2014, Proceedings of the National Academy of Sciences.
[7] M. Morris,et al. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.
[8] Junjie Chen,et al. Tumor Suppressor P53 Binding Protein 1 (53bp1) Is Involved in DNA Damage–Signaling Pathways , 2001, The Journal of cell biology.
[9] W. Mark Saltzman,et al. Synthetic DNA delivery systems , 2000, Nature Biotechnology.
[10] E. Lander,et al. Development and Applications of CRISPR-Cas 9 for Genome Engineering , 2015 .
[11] Ping Zhu,et al. Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells , 2014, Cell Research.
[12] Daesik Kim,et al. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins , 2014, Genome research.
[13] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[14] Junjie Chen,et al. Akt regulates TPP1 homodimerization and telomere protection , 2013, Aging cell.
[15] Peijing Zhang,et al. Deubiquitination and stabilization of PTEN by USP13 , 2013, Nature Cell Biology.
[16] E. Lander,et al. Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.
[17] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[18] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[19] E. Lander,et al. Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.
[20] Stéphanie Panier,et al. Double-strand break repair: 53BP1 comes into focus , 2013, Nature Reviews Molecular Cell Biology.
[21] K. Nakashiro,et al. Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo. , 2010, Biochemical and biophysical research communications.
[22] Hao Yin,et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver , 2014, Nature.
[23] Shuming Nie,et al. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. , 2007, Journal of the American Chemical Society.
[24] Hans Clevers,et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. , 2013, Cell stem cell.
[25] Shulin Li,et al. Electroporation gene therapy: new developments in vivo and in vitro. , 2004, Current gene therapy.
[26] P. Gregory,et al. CRISPR technology for gene therapy , 2014, Nature Medicine.
[27] Facundo D. Batista,et al. RIF1 Is Essential for 53BP1-Dependent Nonhomologous End Joining and Suppression of DNA Double-Strand Break Resection , 2013, Molecular cell.
[28] Francesco Stellacci,et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. , 2008, Nature materials.
[29] Hao Yin,et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype , 2014, Nature Biotechnology.
[30] H. C. Mastwijk,et al. Electroporation of cells in microfluidic devices: a review , 2006, Analytical and bioanalytical chemistry.
[31] Robert Langer,et al. A vector-free microfluidic platform for intracellular delivery , 2013, Proceedings of the National Academy of Sciences.
[32] Wei Tang,et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. , 2013, Cell stem cell.